FDAFDA · Food and drugs·Recall number D-1185-2014
Tivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NC 27709; by: GlaxoSmithKline, Research Triangle Park, NC 27709. Made in Japan. NDC 49702-228-13
Published April 9, 2014 · Recall initiated: February 11, 2014
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination with Other Products: Product contains Promacta (eltrombopag).
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- TIVICAY
- Manufacturer
- Viiv Healthcare Company
- Distributor
- Nationwide including Puerto Rico
- UPC
- 0349702227132
- Lot
- Lot #: 3ZP2210 Sub-lot A, Expiry: 10/15
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.